A phase I study assessing ALV-306 in pouchitis
Latest Information Update: 31 Aug 2020
At a glance
- Drugs ALV 306 (Primary)
- Indications Pouchitis
- Focus Adverse reactions
- 31 Aug 2020 New trial record
- 27 Aug 2020 According to a PureTech Health media release, the company expects to file an IND for ALV-306 in pouchitis and initiate a clinical trial in 2021.